A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study

Clinical trial NCT02578797 · COMPLETED

Trial details

NCT number: NCT02578797
Sponsor: Aragon Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Castration-Resistant Prostate Cancer

Start date: 2015-12-18
Primary completion: 2016-09-20
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.